Structure and mechanism of lanthipeptide biosynthetic enzymes

Current Opinion in Structural Biology

Volumn 29, Issue , 2014, Pages 58-66

  van der Donk, Wilfred A ^a,b   Nair, Satish K ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLASE LANC; CYSTEINE; DEHYDRATASE LANB; ENZYME; LABYRINTHOPEPTIN A2; LANTHIOPEPTIN; LANTIBIOTIC; MERSACIDIN; NISIN; PEPTIDE HYDROLASE; PROTEINASE; SERINE; SUBTILISIN; SULFIDE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; VENEZUELIN; ANTIINFECTIVE AGENT; BACTERIOCIN; EPILANCIN 15X; HYDROLYASE; OXIDOREDUCTASE; PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIBIOTIC BIOSYNTHESIS; BACILLUS SUBTILIS; BACTERIAL STRAIN; CROSS LINKING; CRYSTAL STRUCTURE; DRUG SYNTHESIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; LACTOBACILLUS DELBRUECKII; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS AUREUS; STRUCTURE ANALYSIS; BACTERIUM; BIOSYNTHESIS; CHEMISTRY; METABOLISM; PROTEIN CONFORMATION; RIBOSOME;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOCINS; HYDRO-LYASES; OXIDOREDUCTASES; PEPTIDE HYDROLASES; PEPTIDES; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBOSOMES;

EID: 84908052719     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2014.09.006     Document Type: Review

References (69)

1. Clardy J., Fischbach M.A., Walsh C.T. New antibiotics from bacterial natural products. Nat Biotechnol 2006, 24:1541-1550.
2. Arnison P.G., Bibb M.J., Bierbaum G., Bowers A.A., Bugni T.S., Bulaj G., Camarero J.A., Campopiano D.J., Challis G.L., Clardy J., et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 2013, 30:108-160.
3. McIntosh J.A., Donia M.S., Schmidt E.W. Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds. Nat Prod Rep 2009, 26:537-559.
4. Oman T.J., van der Donk W.A. Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat Chem Biol 2010, 6:9-18.
5. Yang X., van der Donk W.A. Ribosomally synthesized and post-translationally modified peptide natural products: new insights into the role of leader and core peptides during biosynthesis. Chem Eur J 2013, 19:7662-7677.
6. Brötz H., Josten M., Wiedemann I., Schneider U., Götz F., Bierbaum G., Sahl H.-G. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol 1998, 30:317-327.
7. Breukink E., Wiedemann I., van Kraaij C., Kuipers O.P., Sahl H., de Kruijff B. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 1999, 286:2361-2364.
8. Wiedemann I., Breukink E., van Kraaij C., Kuipers O.P., Bierbaum G., de Kruijff B., Sahl H.G. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 2001, 276:1772-1779.
9. Hasper H.E., Kramer N.E., Smith J.L., Hillman J.D., Zachariah C., Kuipers O.P., de Kruijff B., Breukink E. A new mechanism of antibiotic action. Science 2006, 313:1636-1637.
10. Zhang Q., Yu Y., Velásquez J.E., van der Donk W.A. Evolution of lanthipeptide synthetases. Proc Natl Acad Sci U S A 2012, 109:18361-18366.
11. Knerr P.J., van der Donk W.A. Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem 2012, 81:479-505.
12. Siezen R.J., Kuipers O.P., de Vos W.M. Comparison of lantibiotic gene clusters and encoded proteins. Antonie Van Leeuwenhoek 1996, 69:171-184.
13. Goto Y., Li B., Claesen J., Shi Y., Bibb M.J., van der Donk W.A. Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol 2010, 8:e1000339.
14. Krawczyk B., Völler G.H., Völler J., Ensle P., Süssmuth R.D. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase. Chembiochem 2012, 13:2065-2071.
15. Meindl K., Schmiederer T., Schneider K., Reicke A., Butz D., Keller S., Guhring H., Vertesy L., Wink J., Hoffmann H., et al. Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed Engl 2010, 49:1151-1154.
16. Wang H., van der Donk W.A. Biosynthesis of the class III lantipeptide catenulipeptin. ACS Chem Biol 2012, 7:1529-1535.
17. Li B., Yu J.P., Brunzelle J.S., Moll G.N., van der Donk W.A., Nair S.K. Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis. Science 2006, 311:1464-1467.
18. Müller W.M., Schmiederer T., Ensle P., Süssmuth R.D. In vitro biosynthesis of the prepeptide of type-III lantibiotic labyrinthopeptin A2 including formation of a CC bond as a post-translational modification. Angew Chem Int Ed Engl 2010, 49:2436-2440.
19. Velásquez J.E., Zhang X., van der Donk W.A. Biosynthesis of the antimicrobial peptide epilancin 15X and its unusual N-terminal lactate moiety. Chem Biol 2011, 18:857-867.
20. Shi Y., Bueno A., van der Donk W.A. Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli. Chem Commun 2012, 48:10966-10968.
21. Boakes S., Cortés J., Appleyard A.N., Rudd B.A., Dawson M.J. Organization of the genes encoding the biosynthesis of actagardine and engineering of a variant generation system. Mol Microbiol 2009, 72:1126-1136.
22. Cotter P.D., O'Connor P.M., Draper L.A., Lawton E.M., Deegan L.H., Hill C., Ross R.P. Posttranslational conversion of l-serines to d-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc Natl Acad Sci U S A 2005, 102:18584-18589.
23. Lohans C.T., Li J.L., Vederas J.C. Structure and biosynthesis of carnolysin, a homologue of enterococcal cytolysin with d-amino acids. J Am Chem Soc 2014, 136:13150-13153.
24. Maffioli S.I., Iorio M., Sosio M., Monciardini P., Gaspari E., Donadio S. Characterization of the congeners in the lantibiotic NAI-107 complex. J Nat Prod 2014, 77:79-84.
25. Ökesli A., Cooper L.E., Fogle E.J., van der Donk W.A. Nine post-translational modifications during the biosynthesis of cinnamycin. J Am Chem Soc 2011, 133:13753-13760.
26. Widdick D.A., Dodd H.M., Barraille P., White J., Stein T.H., Chater K.F., Gasson M.J., Bibb M.J. Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005. Proc Natl Acad Sci U S A 2003, 100:4316-4321.
27. Iorio M., Sasso O., Maffioli S.I., Bertorelli R., Monciardini P., Sosio M., Bonezzi F., Summa M., Brunati C., Bordoni R., et al. A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity. ACS Chem Biol 2014, 9:398-404.
28. Kupke T., Stevanovic S., Sahl H.G., Götz F. Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin. J Bacteriol 1992, 174:5354-5361.
29. Majer F., Schmid D.G., Altena K., Bierbaum G., Kupke T. The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin. J Bacteriol 2002, 184:1234-1243.
30. Onaka H., Nakaho M., Hayashi K., Igarashi Y., Furumai T. Cloning and characterization of the goadsporin biosynthetic gene cluster from Streptomyces sp. TP-A0584. Microbiology 2005, 151:3923-3933.
31. Wieland Brown L.C., Acker M.G., Clardy J., Walsh C.T., Fischbach M.A. Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin. Proc Natl Acad Sci U S A 2009, 106:2549-2553.
32. Kelly W.L., Pan L., Li C. Thiostrepton biosynthesis: prototype for a new family of bacteriocins. J Am Chem Soc 2009, 131:4327-4334.
33. Liao R., Duan L., Lei C., Pan H., Ding Y., Zhang Q., Chen D., Shen B., Yu Y., Liu W. Thiopeptide biosynthesis featuring ribosomally synthesized precursor peptides and conserved posttranslational modifications. Chem Biol 2009, 16:141-147.
34. Morris R.P., Leeds J.A., Naegeli H.U., Oberer L., Memmert K., Weber E., Lamarche M.J., Parker C.N., Burrer N., Esterow S., et al. Ribosomally synthesized thiopeptide antibiotics targeting elongation factor Tu. J Am Chem Soc 2009, 5946-5955.
35. Garg N., Salazar-Ocampo L.M., van der Donk W.A. In vitro activity of the nisin dehydratase NisB. Proc Natl Acad Sci U S A 2013, 110:7258-7263.
36. Plat A., Kluskens L.D., Kuipers A., Rink R., Moll G.N. Requirements of the engineered leader peptide of nisin for inducing modification, export, and cleavage. Appl Environ Microbiol 2011, 77:604-611.
37. Khusainov R., Heils R., Lubelski J., Moll G.N., Kuipers O.P. Determining sites of interaction between prenisin and its modification enzymes NisB and NisC. Mol Microbiol 2011, 82:706-718.
38. Lubelski J., Khusainov R., Kuipers O.P. Directionality and coordination of dehydration and ring formation during biosynthesis of the lantibiotic nisin. J Biol Chem 2009, 284:25962-25972.
39. Zhang Q., Ortega M., Shi Y., Wang H., Melby J.O., Tang W., Mitchell D.A., van der Donk W.A. Structural investigation of ribosomally synthesized natural products by hypothetical structure enumeration and evaluation using tandem MS. Proc Natl Acad Sci U S A 2014, 111:12031-12036.
40. Park H.W., Boduluri S.R., Moomaw J.F., Casey P.J., Beese L.S. Crystal structure of protein farnesyltransferase at 2.25 angstrom resolution. Science 1997, 275:1800-1804.
41. Blisnick T., Vincensini L., Barale J.C., Namane A., Braun Breton C. LANCL1, an erythrocyte protein recruited to the Maurer's clefts during Plasmodium falciparum development. Mol Biochem Parasitol 2005, 141:39-47.
42. Sturla L., Fresia C., Guida L., Bruzzone S., Scarfi S., Usai C., Fruscione F., Magnone M., Millo E., Basile G., et al. LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells. J Biol Chem 2009, 284:28045-28057.
43. Zhang W., Wang L., Liu Y., Xu J., Zhu G., Cang H., Li X., Bartlam M., Hensley K., Li G., et al. Structure of human lanthionine synthetase C-like protein 1 and its interaction with Eps8 and glutathione. Genes Dev 2009, 23:1387-1392.
44. Chung C.H., Kurien B.T., Mehta P., Mhatre M., Mou S., Pye Q.N., Stewart C., West M., Williamson K.S., Post J., et al. Identification of lanthionine synthase C-like protein-1 as a prominent glutathione binding protein expressed in the mammalian central nervous system. Biochemistry 2007, 46:3262-3269.
45. Huang C., Chen M., Pang D., Bi D., Zou Y., Xia X., Yang W., Luo L., Deng R., Tan H., et al. Developmental and activity-dependent expression of LanCL1 confers antioxidant activity required for neuronal survival. Dev Cell 2014, 30:479-487.
46. Zhong W.X., Wang Y.B., Peng L., Ge X.Z., Zhang J., Liu S.S., Zhang X.N., Xu Z.H., Chen Z., Luo J.H. Lanthionine synthetase C-like protein 1 interacts with and inhibits cystathionine beta-synthase: a target for neuronal antioxidant defense. J Biol Chem 2012, 287:34189-34201.
47. Hensley K., Venkova K., Christov A. Emerging biological importance of central nervous system lanthionines. Molecules 2010, 15:5581-5594.
48. Håvarstein L.S., Diep D.B., Nes I.F. A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Mol Microbiol 1995, 16:229-240.
49. Völler G.H., Krawczyk B., Ensle P., Süssmuth R.D. Involvement and unusual substrate specificity of a prolyl oligopeptidase in class III lanthipeptide maturation. J Am Chem Soc 2013, 135:7426-7429.
50. Kuipers A., De Boef E., Rink R., Fekken S., Kluskens L.D., Driessen A.J., Leenhouts K., Kuipers O.P., Moll G.N. NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides. J Biol Chem 2004, 279:22176-22182.
51. van der Meer J.R., Polman J., Beerthuyzen M.M., Siezen R.J., Kuipers O.P., De Vos W.M. Characterization of the Lactococcus lactis nisin A operon genes nisP, encoding a subtilisin-like serine protease involved in precursor processing, and nisR, encoding a regulatory protein involved in nisin biosynthesis. J Bacteriol 1993, 175:2578-2588.
52. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967, 27:157-162.
53. Siezen R.J., Rollema H.S., Kuipers O.P., de Vos W.M. Homology modelling of the Lactococcus lactis leader peptidase NisP and its interaction with the precursor of the lantibiotic nisin. Protein Eng 1995, 8:117-125.
54. Ortega M.A., Velásquez J.E., Garg N., Zhang Q., Joyce R.E., Nair S.K., van der Donk W.A. Substrate specificity of the lanthipeptide peptidase ElxP and the oxidoreductase ElxO. ACS Chem Biol 2014, 9:1718-1725.
55. Sardar D., Pierce E., McIntosh J.A., Schmidt E.W. Recognition sequences and substrate evolution in cyanobactin biosynthesis. ACS Synth Biol 2014, 10.1021/sb500019b.
56. Kuhn M.L., Prachi P., Minasov G., Shuvalova L., Ruan J., Dubrovska I., Winsor J., Giraldi M., Biagini M., Liberatori S., et al. Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP. FASEB J 2014, 28:1780-1793.
57. Peschel A., Götz F. Analysis of the Staphylococcus epidermidis genes epiF, -E, and -G involved in epidermin immunity. J Bacteriol 1996, 178:531-536.
58. Reis M., Eschbach-Bludau M., Iglesias-Wind M.I., Kupke T., Sahl H.G. Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product. Appl Environ Microbiol 1994, 60:2876-2883.
59. Stein T., Heinzmann S., Solovieva I., Entian K.D. Function of Lactococcus lactis nisin immunity genes nisI and nisFEG after coordinated expression in the surrogate host Bacillus subtilis. J Biol Chem 2003, 278:89-94.
60. Takala T.M., Saris P.E. C terminus of NisI provides specificity to nisin. Microbiology 2006, 152:3543-3549.
61. Draper L.A., Ross R.P., Hill C., Cotter P.D. Lantibiotic immunity. Curr Protein Pept Sci 2008, 9:39-49.
62. Christ N.A., Bochmann S., Gottstein D., Duchardt-Ferner E., Hellmich U.A., Dusterhus S., Kotter P., Guntert P., Entian K.D., Wohnert J. The first structure of a lantibiotic immunity protein, SpaI from Bacillus subtilis, reveals a novel fold. J Biol Chem 2012, 287:35286-35298.
63. Blaesse M., Kupke T., Huber R., Steinbacher S. Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate. EMBO J 2000, 19:6299-6310.
64. Blaesse M., Kupke T., Huber R., Steinbacher S. Structure of MrsD, an FAD-binding protein of the HFCD family. Acta Crystallogr D Biol Crystallogr 2003, 59:1414-1421.
65. Velásquez J.E., van der Donk W.A. Genome mining for ribosomally synthesized natural products. Curr Opin Chem Biol 2011, 15:11-21.
66. Shi Y., Yang X., Garg N., van der Donk W.A. Production of lantipeptides in Escherichia coli. J Am Chem Soc 2011, 133:2338-2341.
67. Tianero M.D., Donia M.S., Young T.S., Schultz P.G., Schmidt E.W. Ribosomal route to small-molecule diversity. J Am Chem Soc 2012, 134:418-425.
68. van Heel A.J., Mu D., Montalban-Lopez M., Hendriks D., Kuipers O.P. Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes. ACS Synth Biol 2013, 2:397-404.
69. Oldach F., Al Toma R., Kuthning A., Caetano T., Mendo S., Budisa N., Süssmuth R.D. Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids. Angew Chem Int Ed 2012, 51:415-418.